XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

600721

CNE000000KQ1

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
5.7 ^CNY	+3.83%		+11.11%	-26.36%

Apr. 25	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index

June 13, 2022 at 12:00 am EDT

Xinjiang Baihuacun Co., Ltd has been added to Shanghai Stock Exchange A Share Index

Latest news about Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	Apr. 23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-10	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-11	CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan	22-12-26	MT
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	22-12-22	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange Composite Index	22-06-13	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index	22-06-13	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Jiangsu Leeway Biological Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Xinjiang Baihuacun Co., Ltd.	21-09-16	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-17	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 338.746321 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	21-05-27	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Xinjiang Baihuacun Co., Ltd. cancelled the transaction announced on June 8, 2020	21-03-04	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-22	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-19	CI
Xinjiang Baihuacun Co., Ltd. Provides Earnings Guidance for the First Half of 2020	20-07-19	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 429.904 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	20-06-07	CI

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Duration

Period

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

More charts

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

Sector

Biotechnology & Medical Research

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	-26.36%	300M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index

Latest news about Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs